Monterey Private Wealth, Inc. Bristol Myers Squibb CO Transaction History

Monterey Private Wealth, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$48.48 - $57.85 $5,381 - $6,421	-111 Reduced 2.39%	4,527 $232,000
Q3 2023 Oct 10, 2023	BUY	$57.89 - $64.73 $2,431 - $2,718	42 Added 0.91%	4,638 $269,000
Q2 2023 Jul 11, 2023	BUY	$63.71 - $70.74 $12,487 - $13,865	196 Added 4.45%	4,596 $293,000
Q1 2023 Apr 06, 2023	SELL	$65.71 - $74.53 $4,796 - $5,440	-73 Reduced 1.63%	4,400 $304,000
Q4 2022 Jan 20, 2023	SELL	$68.48 - $81.09 $22,050 - $26,110	-322 Reduced 6.72%	4,473 $0
Q3 2022 Oct 11, 2022	SELL	$0.13 - $76.84 $83 - $49,100	-639 Reduced 11.76%	4,795 $344,000
Q2 2022 Jul 13, 2022	BUY	$72.62 - $79.98 $48,945 - $53,906	674 Added 14.16%	5,434 $418,000
Q1 2022 Apr 08, 2022	SELL	$61.48 - $73.72 $1,045 - $1,253	-17 Reduced 0.36%	4,760 $351,000
Q4 2021 Jan 18, 2022	BUY	$53.63 - $62.52 $482 - $562	9 Added 0.19%	4,777 $298,000
Q3 2021 Oct 08, 2021	BUY	$59.17 - $69.31 $473 - $554	8 Added 0.17%	4,768 $282,000
Q2 2021 Aug 30, 2021	BUY	$61.91 - $67.42 $29,407 - $32,024	475 Added 11.09%	4,760 $318,000
Q1 2021 Apr 28, 2021	BUY	$59.34 - $66.74 $1,364 - $1,535	23 Added 0.54%	4,285 $282,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $404 - $458	7 Added 0.16%	4,262 $264,000
Q3 2020 Feb 24, 2021	BUY	$57.43 - $63.64 $459 - $509	8 Added 0.19%	4,255 $257,000
Q2 2020 Feb 24, 2021	BUY	$54.82 - $64.09 $438 - $512	8 Added 0.19%	4,247 $250,000
Q1 2020 Feb 24, 2021	SELL	$46.4 - $67.43 $15,915 - $23,128	-343 Reduced 7.49%	4,239 $236,000
Q4 2019 Feb 24, 2021	BUY	$49.21 - $64.19 $225,480 - $294,118	4,582 New	4,582 $294,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Monterey Private Wealth, Inc., based on Form 13F filings with the SEC.

Stay updated on Monterey Private Wealth, Inc. with notifications on news.